Trial sites conducting Covaxin study say the company has given them an indicative deadline of 31 December to complete the recruitment of volunteers, but company denies claim.
Turkey said a trial of Sinovac’s vaccine showed an estimated efficacy rate of 91.25%. However, Sao Paulo Health Secretary said the vaccine 'didn’t reach 90%' efficacy.
Anurag Agrawal, director of CSIR's Institute of Genomics and Integrative Biology, said big outbreak in India with new virus strain is unlikely unless there is an escape from immunity.
Researchers, however, said evaluation of safety outcomes required extensive phase 3 clinical trials of the Covid vaccine developed through partnership between ICMR & Bharat Biotech.
Fertility rates have dipped across states, indicating India's population is stabilising. Experts point to several factors, including an increase in contraceptive use.
The PM did make a valid point when he criticised the Congress for categorising the entire Muslim community in Karnataka under the Other Backward Classes. It is pure appeasement of Ashraaf Muslims and discriminates against Pasmandas.
Speaking at launch of economist Surjit Bhalla’s book, S Jaishankar also highlights Gen Z’s engagement with ‘reel culture’, which has 'promoted awareness, created interest in many subjects'.
Germany’s erstwhile Christian Democratic Union govt, led by Angela Merkel, prevented sale of small arms to police forces in states they perceived had ‘bad human rights record’.
Increase the number of testing sites immediately. Though it is not so easy, ICMR can do it. There must a number of good hospitals and doctors in Tier 2 & 3 cities and they can be tapped. Go international. As Indian vaccines will be cheaper than other vaccines, a number of 3rd world countries will be willing to use our vaccines particularly when they are already teste in those countries. Cost of testing will increase but can be recovered in the cost of vaccine. A short term bridge loan can be arranged for the company.
Bharat Biotech should publish the average economic status of the volunteers. Recruiting thousands of illiterate volunteers who are poorer than the poorest, who cannot comprehend the side-effects of the testing, is a blatant violation of human rights.
Please share contact details where volunteer can register themselves. I am trying to get number since 7:00 today. Please share it with me.
Increase the number of testing sites immediately. Though it is not so easy, ICMR can do it. There must a number of good hospitals and doctors in Tier 2 & 3 cities and they can be tapped. Go international. As Indian vaccines will be cheaper than other vaccines, a number of 3rd world countries will be willing to use our vaccines particularly when they are already teste in those countries. Cost of testing will increase but can be recovered in the cost of vaccine. A short term bridge loan can be arranged for the company.
Bharat Biotech should publish the average economic status of the volunteers. Recruiting thousands of illiterate volunteers who are poorer than the poorest, who cannot comprehend the side-effects of the testing, is a blatant violation of human rights.
they should also publish the political affiliations as well